A Brussels biotech company got 37 million euro for their research into cancer therapy based on camel antibodies. Their medication is meant to fight brain tumours.
A Brussels biotech company got 37 million euro for their research into cancer therapy based on camel antibodies. Their medication is meant to fight brain tumours.
Fijn dat je wil reageren. Wie reageert, gaat akkoord met onze huisregels. Hoe reageren via Disqus? Een woordje uitleg.